Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

Background/Aims: Aspirin has been demonstrated to possess potent chemopreventive and anticancer effects on prostate cancer. However, the more detailed molecular mechanisms of aspirin to suppress prostate cancer cell invasion have not been clearly elucidated. Methods: Transwell assays were performed...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Chongjun Shi, Nini Zhang, Yang Feng, Jiewei Cao, Xuyi Chen, Bin Liu
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Cell Physiol Biochem Press GmbH & Co KG 2017-03-01
Saila:Cellular Physiology and Biochemistry
Gaiak:
Invasion
Matrix metalloproteinase
Nuclear factor-kappa B
Prostate cancer
Urokinase-type plasminogen activator
Sarrera elektronikoa:http://www.karger.com/Article/FullText/464434

Antzeko izenburuak

Antzeko izenburuak